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Abstract
Background: Enterohemorrhagic E. coli (EHEC), a subgroup of Shiga toxin (Stx) producing E. coli
(STEC), may cause severe enteritis and hemolytic uremic syndrome (HUS) and is transmitted orally
via contaminated foods or from person to person. The infectious dose is known to be very low,
which requires most of the bacteria to survive the gastric acid barrier. Acid resistance therefore is
an important mechanism of EHEC virulence. It should also be a relevant characteristic of E. coli
strains used for therapeutic purposes such as the probiotic E. coli Nissle 1917 (EcN). In E. coli and
related enteric bacteria it has been extensively demonstrated, that the alternative sigma factor σS,
encoded by the rpoS gene, acts as a master regulator mediating resistance to various environmental
stress factors.
Methods: Using rpoS deletion mutants of a highly virulent EHEC O26:H11 patient isolate and the
sequenced prototype EHEC EDL933 (ATCC 700927) of serotype O157:H7 we investigated the
impact of a functional rpoS gene for orchestrating a satisfactory response to acid stress in these
strains. We then functionally characterized rpoS of probiotic EcN and five rpoS genes selected from
STEC isolates pre-investigated for acid resistance.
Results: First, we found out that ATCC isolate 700927 of EHEC EDL933 has a point mutation in
rpoS, not present in the published sequence, leading to a premature stop codon. Moreover, to our
surprise, one STEC strain as well as EcN was acid sensitive in our test environment, although their
cloned rpoS genes could effectively complement acid sensitivity of an rpoS deletion mutant.
Conclusion: The attenuation of sequenced EHEC EDL933 might be of importance for anyone
planning to do either in vitro or in vivo studies with this prototype strain. Furthermore our data
supports recently published observations, that individual E. coli isolates are able to significantly
modulate their acid resistance phenotype independent of their rpoS genotype.
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Background
Enterohemorrhagic Escherichia coli (EHEC), a subgroup of
Shiga toxin (Stx) producing E. coli (STEC), are enteric
pathogens frequently causing severe illness in humans.
EHEC infection may lead to non-bloody and bloody
diarrhea and most dangerously, the extraintestinal com-
plication hemolytic uremic syndrome (HUS) [1,2]. In
order to cause gastrointestinal disease, bacteria must pass
through the acidic gastric barrier. When taking into
account the apparent low infectious dose of enterohemor-
rhagic E. coli, which may be as little as 100 viable organ-
isms [3], it becomes obvious that acid resistance is an
important virulence trait of EHEC. Investigation of the
complex mechanisms conferring acid tolerance onto E.
coli has revealed many new insights in the last years. Cur-
rently, four different acid stress protection systems are
being discussed. At least three of these are controlled by
σS, an alternative sigma subunit of RNA polymerase
encoded by the rpoS gene [4]. σS, which is seen as a master
regulator of general stress response, confers promoter spe-
cificity to the core RNA polymerase and is activated under
a variety of stress conditions, as well as during stationary
phase [5-7]. The glutamate-dependent acid resistance
(GDAR) system is believed to provide best protection for
bacterial cells below pH 3 [8]. Bhagwat et al. have recently
reported, that in natural populations of pathogenic E. coli
mutations in gadE exist which, in addition to mutant alle-
les of rpoS, may contribute to varying acid resistance phe-
notypes of EHEC [9]. gadE encodes the GadE protein, a
regulatory molecule of the GDAR system [10].
In 1994 Small et al. already reported that the growth pH
is important for expression of acid resistance in E. coli
[11]. Waterman et al. who have investigated a large set of
STEC for acid resistance [12], identified defective rpoS
genes as cause for loss of acid resistance in individual E.
coli isolates. Recently it was demonstrated by King et al.,
that modulation of genome usage enables regulatory
diversity which contributes to strain variation in E. coli
[13]. A similar observation was reported by Bhagwat et al.,
who investigated stress tolerance of EHEC and could
observe a functional heterogeneity of RpoS [14].
Our study was initially focused on analyzing the role of σS
in acid stress behavior of two different EHEC isolates used
as model organisms in our laboratory: the sequenced pro-
totype O157:H7 EHEC EDL933 (ATCC 700927) [15] and
a very well characterized EHEC O26:H11 isolate from a
HUS patient [16,17]. We expected these results to improve
the interpretation of data obtained from in vitro and in vivo
virulence experiments investigating pathogen-host inter-
actions. Using homologous recombination and suicide
vector technique we constructed unmarked isogenic rpoS
deletion mutants of both strains. Resistance of wild type
organisms and their mutants towards acidic conditions at
pH 2.5 and 1.5 were tested as described by Lange et al.
[18] with slight modifications. While the EHEC O26:H11
patient isolate was highly dependent on a functional rpoS
gene for an adequate response to acid stress, surprisingly,
deletion of rpoS  in EHEC EDL933 had no measurable
effect when compared to its wild type strain. Further
investigation revealed a point mutation in the EHEC
EDL933 rpoS gene which leads to a TAA stop codon being
responsible for this phenotype.
We then evaluated another 39 isolates of human and por-
cine origin and functionally characterized a subgroup of
five selected rpoS genes. Surprisingly, σS activity of STEC
ED-68 [19,20] appeared to be dependent on a yet
unknown regulatory mechanism that modulated its activ-
ity. In the following, we could also observe a similar phe-
nomenon with the well characterized probiotic E. coli
Nissle 1917 [21-23].
Results
Construction and confirmation of unmarked isogenic rpoS 
deletion mutants
After PCR screening of potential mutants one rpoS nega-
tive isolate of each EHEC wild type strain, EDL933a and
126814 (Table 1), was subjected to further testing by
Southern blotting. They both showed DNA fragments of
the expected size, after restriction digest of their genomic
DNA with either XmnI or StuI [see Additional file 1]
thereby indicating the correct insertion of the rpoS dele-
tion mutation into the genome of the two EHEC strains.
The mutants were termed E. coli MHH933-5 and
MHH126-5 respectively. Additionally, the mutation was
confirmed by DNA sequencing of a PCR product gener-
ated with primers RpoS 3 and RpoS 4. Antibiotic resist-
ance patterns of the mutants did not differ from their
parental strains. Biochemical reaction profiles of all
strains, as determined with API 20 E strips, were quite sim-
ilar [see Additional file 2]. EHEC EDL933a and its mutant,
which both could not ferment sorbitol, were identified as
89.6 % E. coli according to their API profile index
"5144172". Sorbitol positive EHEC 126814 and mutant
strain  E. coli MHH126-5 generated the profile index
"5144562" which was 99.8 % specific for E. coli. Addition-
ally, all E. coli O157:H7 isolates were able to ferment
rhamnose, while the O26:H11 strains were not. After 1 h
treatment with 30 mM hydrogen peroxide no viable bac-
teria could be recovered from cultures of E. coli MHH933-
5, MHH126-5 and EHEC EDL933a, while EHEC 126814
and EDL933b (Table 1) still produced more than 60 %
colony forming units (CFU) compared to the blank value
(data not shown).
Acid resistance assays
The strains became acid resistant from OD600  0.7 for
EHEC 126814 and from OD600 1.2 for EHEC EDL933a,BMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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respectively. EHEC 126814 very effectively responded to
acid stress (Fig. 1A) and showed resistance rates up to 115
% at pH 2.5, indicating bacterial growth at this low pH,
and 75 % at pH 1.5. In contrast, EHEC EDL933a was only
moderately acid resistant at pH 2.5 as was its isogenic
ΔrpoS mutant (Fig. 1B). The survival of these strains was
about 17 % at most, which appeared to be independent of
the  rpoS  genotype. The behavior of a second clone of
EHEC EDL933a, obtained from ATCC, was identical (data
not shown). EHEC EDL933b however, was nearly as acid
resistant as EHEC 126814 (Fig. 1A and 1B). Furthermore,
E. coli MHH126-5 was completely unable to survive acidic
growth conditions at pH 2.5 and pH 1.5 (Fig. 1A). By
complementation of E. coli MHH126-5 with pSC1 bearing
its own rpoS gene, a wild type like phenotype could be
restored. At pH 2.5 it was even more resistant than the
parental organism. At pH 1.5 its survival was still about 60
% (Fig. 1C). When complemented with pSC2, harboring
rpoS*, the rpoS  gene from EHEC EDL933a,  E. coli
MHH126-5 was completely sensitive to acidic growth
conditions further on (data not shown). However, when
E. coli MHH126-5 was transformed with plasmid pMH33,
containing an rpoS* allele cured by site directed mutagen-
esis from the TAA stop codon at position 723, its acid
resistance increased to more than 100 % (data not
shown). Thus, we could unequivocally prove that the
point mutation G721T in rpoS* was solely responsible for
the acid sensitive phenotype of EHEC EDL933a.
Homology comparison of rpoS genes
Homology of all sequenced rpoS  genes was compared
with the software package BioEdit [see Additional file 3].
In the following all nucleotide positions are enumerated
as described in materials and methods. We again
sequenced the rpoS gene of EHEC EDL933b and used it as
reference for all comparisons since the respective nucle-
otide data from the genome sequence NC_002655 had
two sequencing errors, G57C and G61C. The main rpoS
promoter rpoSp is located within the nlpD gene at position
-568 to -566. The 35 and the -10 region are positioned at
-601 to -596 and -578 to -573 respectively. Both, the
highly acid resistant EHEC strain 126814 as well as the
STEC isolate E-D53 had the point mutation G-570A,
located in between the 10 region and rpoSp. Furthermore,
these strains had point mutation A-521G leading to an
amino acid exchange from threonine to alanine in NlpD.
EHEC 126814 and 288597, STEC E-D53 and E-D68 and
EcN also showed mutations T-306C in the nlpD gene, as
well as A543C in rpoS. With the exception of EHEC
288597, these strains were mutated at position T387C as
well. EHEC 126814 and the two STEC strains E-D53 and
E-D68 also carried mutation A819G. Furthermore, EHEC
126814 and STEC E-D53 had the additional mutation G-
465A in nlpD. STEC E-D68 showed four more point muta-
tions: C-472T, which leads to an amino acid exchange
from threonine to isoleucine in NlpD, C-293T, G-183T
and A-162G. EcN carried the nucleotide exchange C-463T
resulting in isoleucine instead of threonine in NlpD. Fur-
thermore, the rpoS  gene of EcN had point mutations
T171C, C272T, T365G, T470C, T581C, and C995T.
Except for the three amino acid exchanges in NlpD
described above, all other point mutations observed in
either rpoS or nlpD of all E. coli strains investigated were
silent. In contrast, EHEC 86-24 had an 8 bp duplicate
sequence (GAAGAGGA) in rpoS beginning at position 131
which caused a shift in the open reading frame and a stop
codon 219 bp later.
Functional analysis of further rpoS genes
All experiments are illustrated in figure 2. Plasmids pUD2,
pUD8 and pUD10 conferred a highly acid resistant phe-
notype on to E. coli MHH126-5, comparable to the respec-
tive wild type organisms EHEC EDL933b, EHEC 288597
and STEC E-D53. As expected, complementation with
pUD4 did not mediate acid resistance to E. coli MHH126-
5. This behavior was comparable to the parental strain
EHEC 86-24. However, when the test strain E. coli
MHH126-5 was transformed with pUD6, surprisingly it
became strongly acid resistant. This was in sharp contrast
to the manner of the corresponding wild type strain STEC
E-D68, which only showed an acid resistance ≤ 0.1 %.
This response becomes comprehensible considering the
Table 1: Bacterial strains investigated in this study.
Laboratory code stx genotype Serotype Reference
EDL933a (ATCC 700927) stx1, stx2 O157:H7 [15]
EDL933b (ATCC 43895/LMG 
15068)
stx1, stx2 O157:H7 [32]
126814/97 stx2 O26:H11 [16,17]
86-24 stx2 O157:H7 [37]
E-D53 stx2e O101: H- [19,20]
E-D68 stx2e O101: H- [19,20]
288597/03 stx2 O157:H- This study
Nissle 1917 ∅ O6:H1 [21-23]
All bacterial strains investigated in detail in this study are listed with their laboratory codes, stx genotype, serotype and references, if applicable.BMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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A: Acid resistance of EHEC 126814 and E. coli MHH126-5 Figure 1
A: Acid resistance of EHEC 126814 and E. coli MHH126-5. Inducible acid resistance of EHEC wild type strain 126814 
and its isogenic rpoS deletion mutant E. coli MHH126-5 was investigated after 2 h incubation in LB media at pH 2.5 or 1.5. The 
wild type strain showed a high level of acid resistance, which was induced from OD600 0.7 of the preparatory culture. It 
reached up to 115 % survival at OD600 2.5 of the starter culture, indicating that EHEC 126814 was able to grow under these 
conditions. In LB media with pH 1.5 up to 75 % of the inoculum survived. E. coli MHH126-5 was completely sensitive to acid 
treatment regardless of pH and OD600 of the preparatory culture. Percentage survival figures in relation to OD600 of one typi-
cal experiment are depicted. The means and standard deviations were calculated from three independent dilution series made 
at each individual measuring point. B: Acid resistance of EHEC EDL933a, EDL933b and E. coli MHH933-5. EHEC 
EDL933b was very acid resistant in all experiments. However, between EHEC wild type strain EDL933a and its mutant E. coli 
MHH933-5 no differences could be observed. Both isolates showed weak resistance under acidic growth conditions and 
showed a similar behavior in all other experiments. In contrast to EHEC 126814, acid resistance of the O157 isolates was 
induced at OD600 1.2 of the starter culture. One typical experiment has been shown as a representation of all independent 
tests carried out. The means and standard deviations were calculated from three independent dilution series prepared at each 
individual measuring point. C: Acid resistance of E. coli MHH126-5 complemented with pSC1. This figure depicts the 
inducible acid resistance in relation to OD600 of one typical experiment. Acid resistance was assayed at pH 2.5 and 1.5. By com-
plementation of rpoS deletion mutant E. coli MHH126-5 with pSC1, containing its own rpoS gene cloned into plasmid pBR322, a 
phenotype could be restored that was even more resistant to acid stress than wild type strain EHEC 126814. OD600 of acid 
resistance induction was identical to values obtained with the wild type strain, shown in figure 1A. In order to compare growth 
conditions in LB media containing ampicillin, positive control EHEC 126814 had been transformed with plasmid pBR322. Com-
pared to figure 1A, the antibiotic and/or pBR322 negatively influenced acid resistance of this strain. The percentage survival at 
pH 2.5 was below 90 %. One typical experiment is shown representative of independent tests. The means and standard devia-
tions were calculated from three independent dilution series made at each individual measuring point.
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unaffected open reading frame in the rpoS sequence of
pUD6. To confirm this effect we constructed pUD9, a sec-
ond independent plasmid containing rpoS from STEC E-
D68. With this plasmid the acid resistance of comple-
mented E. coli MHH126-5 was identical to pUD6. Inter-
estingly, we observed a similar phenomenon when we
investigated acid tolerance of probiotic EcN. While sur-
vival of the wild type organism after pH 2.5 treatment was
only around 5 %, test strain E. coli MHH126-5 became
fully acid resistant, when complemented with plasmid
pDS4 containing rpoS of EcN (Fig. 2).
Discussion
Gastric acid is a natural barrier that all bacteria entering
the lower intestine have to pass. With pH values ranging
between 1.5 and 2.5, the stomach is one of the most
inhospitable areas in the human body. A correlation
between an infectious dose of enterobacteriaceae and
their capacity to withstand acidic conditions is well
known. With respect to the very low infectious dose of
EHEC, of about 100 to 1000 organisms [3], it becomes
obvious, that acid resistance is a key factor for virulence of
these bacteria. E. coli have developed elegant regulatory
systems, that enable their survival under such conditions
[4,24]. The alternative sigma factor σS is instrumental in
the regulation of acid protection mechanisms in this spe-
cies of enterobacteriacae [4].
In this study we have investigated the role of the rpoS gen-
otype on the acid stress response of a set of Shiga toxin
producing E. coli as well as the widely used probiotic E.
coli  strain Nissle 1917 [21-23]. We first constructed
unmarked isogenic rpoS deletion mutants of the highly
virulent EHEC patient isolate 126814 [16,17] and of the
completely sequenced prototype EHEC EDL933 [15],
labeled EHEC EDL933a in this study. The patient isolate
was highly dependent on a functional rpoS gene for an
adequate response to acid stress. By complementation of
its rpoS deletion mutant E. coli MHH126-5 with the rpoS
gene from EHEC 126814 a wild type like phenotype could
be restored. Surprisingly, EHEC EDL933a and its mutant
did not exhibit major differences regarding their acid tol-
erance, but both appeared to be σS defective. Indeed,
when we sequenced rpoS* from EHEC EDL933a we could
identify a point mutation that caused a premature stop
codon which was in conflict with the published database
sequence [15]. In order to rule out that this mutation was
an artifact generated in our laboratory, we purchased a
second isolate of sequenced EHEC EDL933. It carried the
identical point mutation, which may have occurred dur-
ing passage prior to storage of the isolate at the strain col-
lection. Allelic variations in the rpoS  gene are not
uncommon since it is localized in a highly mutable region
of the E. coli genome [25,26]. In a large study Waterman
et al. identified EHEC strains that were defective in their
response to low pH [12]. They attributed this phenotype
to a non functional σS as a consequence of rpoS mutations.
Phenotypical characterization of EHEC EDL933b, a fur-
ther clone of EDL933, and complementation experiments
clearly showed that the stop codon in rpoS* causally deter-
mined the stress phenotype of ATCC strain 700927. When
considering the significant impact of σS in the regulatory
network of E. coli, which controls up to 10 % of the E. coli
genes directly or indirectly [27], this observation is of
importance for those working in the field of EHEC and
planning to do both, in vitro or in vivo studies with this
particular sequenced isolate.
Further investigation of six rpoS genes from Shiga toxin
producing E. coli and a probiotic E. coli strain revealed that
σS activity is not always dependent on the rpoS genotype.
Despite having a functional rpoS gene, as shown by com-
plementation experiments in a ΔrpoS background, STEC
E-D68 as well as EcN behaved σS defective regarding their
acid resistance. While STEC E-D68 was completely sensi-
tive to acid stress, probiotic EcN exhibited about 5 % sur-
vival in the same test environment. With respect to EcN,
this observation adds to an actual study of Bhagwat et al.
where the authors observed functional heterogeneity of σS
in food-borne and clinical EHEC isolates [14]. However,
in STEC E-D68 as well as in EcN, mutations in the gene
encoding the GDAR system regulator GadE [10] have to
be ruled out. Such mutations have been reported by Bhag-
wat et al. as another reason for attenuated acid resistance
in E. coli wild type isolates [9]. With regard to the varying
σS activities in individual E. coli strains observed in our
study, it should be mentioned that all isolates analyzed
here carried glutamate at codon 33 (GAG) resulting in σS
(33E). This seems to account for a higher variability in
rpoS related phenotypes as recently described by Atlung et
al. [25].
Price et al. have shown recently, that EHEC make use of
their different acid resistance systems depending on the
type of acid stress they are exposed to [28,29]. In either
case σS was important for a sufficient acid stress response
of EHEC EDL933 (ATCC 43895) in vitro as well as in vivo
[29]. It should be investigated though, whether this
impact of σS on the in vivo acid resistance of EHEC also
allows assumptions about the virulence of a particular
strain. In our laboratory environment for instance wild
type EHEC 86-24 was highly virulent in an oral infection
model with gnotobiotic piglets [16], although it has a non
functional rpoS gene and is only weakly acid resistant as
shown above. Krogfelt et al. have published an accom-
plished experiment which clearly demonstrates that rpoS
gene function may be a disadvantage for E. coli colonizing
the intestine [30]. The authors therefore conclude that the
benefit of a functional rpoS regulon for E. coli depends on
the actual growth phase of a particular strain. The appar-BMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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ent down regulation of σS activity in STEC E-D68 and EcN
in our study seems to be another way of adapting the rpoS
regulon to specific growth conditions. We have performed
further experiments to investigate the impact of rpoS in
EcN on regulation of potential host probiotic marker
genes which we have recently identified [31]. Our long-
term objective is to establish to what extent E. coli is able
to modulate pathogenic but also beneficial properties
using its rpoS regulatory network.
Conclusion
The results of our study clearly confirm the central role of
σS as a key regulator for acid resistance in STEC and EcN.
When interpreting in vitro or in vivo data generated with
EHEC EDL933a it is important to realize, that this proto-
type EHEC has an attenuated σS phenotype. We could also
show that rpoS gene function is modified in singular E. coli
isolates by regulatory mechanisms that lead to an altered
σS activity, as exemplified by STEC strain E-D68 and pro-
Functional analysis of further rpoS genes by complementation of E. coli MHH126-5 Figure 2
Functional analysis of further rpoS genes by complementation of E. coli MHH126-5. This figure shows resistance 
data of the rpoS deletion mutant E. coli MHH126-5 complemented with each of the plasmids pUD2 (pBR322 + rpoSEDL933b), 
pUD4 (pBR322 + rpoS86-24), pUD10 (pBR322 + rpoS288597), pUD8 (pBR322 + rpoSE-D53), pUD6 (pBR322 + rpoSE-D68), pUD9 
(pBR322 + rpoSE-D68) or pDS4 (pBR322 + rpoSEcN) in comparison to the corresponding wild type EHEC strains EDL933b, 86-24 
and 288597, STEC isolates E-D53 and E-D68 as well as EcN. All wild type strains are indicated by black bars, the comple-
mented mutants by grey ones. Plasmids pUD2 and pUD4, pUD10 and pUD8 conferred an acid resistance phenotype to the 
mutant, which was comparable to the corresponding parental strain. Interestingly, upon complementation with pUD6 and 
pUD9, bearing the rpoS gene of STEC E-D68, E. coli MHH126-5 became strongly pH resistant. This was in sharp contrast to the 
behavior of the STEC E-D68 wild type strain. A similar phenomenon was observed when the acid resistance test strain E. coli 
MHH126-5 was complemented with pDS4 containing rpoS of EcN. The means and standard deviations were calculated from 
three independent dilution series in this exemplary experiment.
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biotic EcN. This is in line with the observations regarding
functional heterogeneity of RpoS in stress tolerance of K-
12 E. coli strains and EHEC isolates, King et al. and Bhag-
wat et al. have reported [13,14], and expands them to a
commensal E. coli with beneficial traits.
Methods
Bacterial strains and media
All bacterial strains investigated in detail in this study are
listed in table 1. Acid stress response assays were per-
formed with EHEC 126814, a highly virulent patient iso-
late [16,17] and the prototype O157:H7 EHEC EDL933.
Two independent clones of EHEC EDL933 were used, the
sequenced strain ATCC 700927 [15], referred to as EHEC
EDL933a  and the original isolate ATCC 43895/BCCM
LMG 15068 [32], termed EHEC EDL933b. Acid resistance
was also evaluated using 39 human and porcine EHEC
and STEC strains (data not shown) as well as the probiotic
E. coli Nissle 1917 [21-23]. Unmarked isogenic rpoS nega-
tive mutants were produced from EHEC EDL933a and
from EHEC 126814. E. coli SM 10 λpir is a λ lysogen of E.
coli SM10 and contains the trans acting factors needed to
replicate and mobilize all suicide plasmids [33] used in
this study. E. coli DH5α (Invitrogen, Karlsruhe, Germany)
was used as host strain for all other plasmids. Bacteria
were grown in LB broth (Invitrogen) and on MacConkey
agar (Oxoid, Wesel, Germany), MH agar (Becton Dickin-
son, Heidelberg, Germany) or LB agar plates (Invitrogen)
at 37°C or on LB sucrose plates (10 % sucrose w/v, no
NaCl) at room temperature. Ampicillin (Ratiopharm,
Ulm, Germany) was added at a concentration of 200 μg/
ml, where necessary. Concentrated HCl was used to adjust
LB broth for acid resistance testing at pH 2.5 or 1.5. Chem-
icals were obtained from Sigma, Deisenhofen or Merck,
Darmstadt, Germany.
Primers and sequencing
Table 2 lists all oligonucleotide primers used in this study.
These were synthesized by MWG-Biotech (Ebersberg, Ger-
many), who also completed the custom sequencing of
PCR products and plasmids. Sequences of all nlpD-rpoS
genes investigated in this study were generated by primer
walking with two independent PCR products for which
corresponding accession numbers are given in table 3.
Nucleotide data was analyzed with the DNASTAR soft-
ware package (Lasergene, DNASTAR, Madison, WI, USA),
the BioEdit Sequence Alignment Editor 7.0.5.3. [34] and
Clone Manager 6 (Scientific & Educational Software, Cary,
NC, USA) and then submitted to GenBank. Nucleotide
positions within rpoS, nlpD or the flanking regions are ref-
erenced to the open reading frame of rpoS. Positions 5'
upstream of the rpoS start codon are indicated with a neg-
ative sign, positions 3' downstream of the stop codon with
a positive one.
Plasmids and DNA preparation
All plasmids used in this study are listed in table 3. Allelic
exchange experiments were conducted with the suicide
vector pMHH8 derived from plasmid pGP704 [33]. A
map of suicide vectors pMHH1, pMHH7 and pMHH8 is
shown in figure 3. All other cloning was performed in
pUC19 [35] or pBR322 [36]. Construction of all comple-
mentation plasmids is depicted in figure 4. Plasmid DNA
was isolated using the Qiagen Plasmid Midi Kit (Qiagen,
Hilden, Germany). Chromosomal DNA was purified with
Qiagen-tip 100 columns and the Genomic DNA Buffer Set
from Qiagen.
Suicide vector pMHH8
For construction of suicide vector pMHH8 the rpoS gene
from EHEC 86-24 [37] was amplified by PCR using prim-
ers RpoS 3/RpoS 4 and cloned into pUC19. Upon restric-
tion digest with enzymes DraIII and BsaI (New England
Biolabs, Schwalbach, Germany) a 390 bp deletion in rpoS
was created. The mutated gene was then subcloned into
pMHH1, a derivative of suicide vector pGP704. The result-
ing plasmid was called pMHH8 (Fig. 3). It contained a
positive selection system based on the sacB  gene from
Bacillus subtilis [38] to facilitate screening for potential
mutants. Electroporation was used to transform E. coli SM
10 λpir with pMHH8.
Construction of complementation plasmids
For complementation experiments, an nlpD-rpoS  DNA
amplicon, containing the rpoS main promoter rpoSp [39]
was generated by PCR using primers with 5' HindIII
restriction sites (Table 2). RpoS 8 and RpoS 9 were taken
to amplify nlpD-rpoS from EHEC strains 126814 (pSC1),
EDL933a  (pSC2), EDL933b  (pUD2), 86-24 (pUD4),
288597 (pUD10) and from porcine STEC strain E-D53
(pUD8). RpoS 8 and RpoS 4c were needed to synthesize
the respective DNA fragment from porcine STEC E-D68
(pUD6 and pUD9). Amplification of nlpD-rpoS from EcN
(pDS4) was performed with primers RpoS 8 and RpoS 22.
Following endonuclease digest, the amplicon was cloned
into the low copy plasmid pBR322 linearized with HindIII
(New England Biolabs). Plasmid pMH33 was produced
from pSC2 by the PCR mediated nucleotide exchange
T721G with primers RpoS 17a/RpoS 17b using the Quik-
Change Site Directed Mutagenesis Kit from Stratagene
(Amsterdam, The Netherlands) according to manufac-
turer's instructions. rpoS deletion mutant E. coli MHH126-
5 was then transformed with each of the complementa-
tion vectors by electroporation.
Construction of rpoS deletion mutants from EHEC 
EDL933a and EHEC 126814
Allelic exchange using suicide vector pMHH8 was per-
formed in a two-step procedure as previously described
[40]. A positive selection system based on the sacB geneBMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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from Bacillus subtilis [38] was used to facilitate screening
for potential mutants.
Genotypical and phenotypical confirmation of mutant 
strains
The  rpoS deletion mutation was confirmed by the
sequencing of PCR products obtained with primers RpoS
3 and RpoS 4, as well as with Southern hybridizations of
chromosomal DNA from EHEC EDL933a  and EHEC
126814 wild type and mutant strains digested with either
StuI or XmnI (New England Biolabs) [see Additional file
1]. Hybridization was performed under high stringency
conditions with digoxigenin labelled probes using the Dig
Labeling and Detection Kit from Roche Diagnostics (Man-
nheim, Germany). Specific binding was detected by auto-
radiography and chemoluminescence with CSPD
(Applied Biosystems, Darmstadt, Germany) as substrate.
API 20 E strips (bioMérieux Deutschland, Nürtingen, Ger-
many) were used to analyze biochemical profiles of
mutants and their parental strains. Antibiotic resistances
of all isolates were determined with the MERLIN Microdi-
lution Detection System (MICRONAUT-SB, MERLIN
Diagnostika, Bornheim-Hersel, Germany). Resistance of
EHEC EDL933a, EDL933b, 126814 and of the mutants E.
coli MHH933-5 and MHH126-5 to 30 mM hydrogen per-
oxide was tested as described by Lange et al. [18]. Viability
of bacteria was evaluated after 5, 10, 20, 30 and 60 min-
utes of H2O2 treatment.
Acid resistance assays
Inducible acid resistance of EHEC EDL933a, EHEC
EDL933b, EHEC 126814, the mutants E. coli MHH933-5
and MHH126-5 as well as of E. coli MHH126-5 comple-
mented with pSC1, pSC2 or pMH33, was assessed by
inoculating 100 ml LB broth pH 7.0 1:1000 with an over-
night culture from each bacterial strain. Bacteria were
sampled at defined time points, as depicted in figure 1A to
1C, and subjected to incubation at pH 2.5 or 1.5 for two
hours. Colony forming units (CFU) of untreated and acid
treated cultures were determined. Acid resistance screen-
ing of further EHEC and STEC isolates, of EcN and of E.
coli  MHH126-5 complemented with pUD2, pUD4,
pUD6, pUD8, pUD9, pUD10 or pDS4 was performed in
a similar manner but as a one step test at pH 2.5, with cul-
tures grown to an OD600 of 1.7 (Fig. 2). Acid resistance
was calculated as percentage CFU recovered after acid
exposure compared to untreated cultures. Resistance data
has been based on three independent tests.
Complementation experiments with mutant E. coli MHH 
126-5
E. coli strain MHH126-5 was transformed with each of the
complementation plasmids by electroporation. Inducible
resistance at pH 2.5 or 1.5 was assayed with E. coli
MHH126-5 complemented with pSC1 (Fig. 1C), using the
same experimental procedure as described above, except
for adding 200 μg/ml ampicillin to all media. Functional
Table 2: Oligonucleotide primers used in this study.
Target gene Name Position 5' Sequence 3' ⇔
rpoS RpoS 3 4 – 24 GCT CTA GAA GTC AGA ATA CGC TGA AAG TT
XbaI
s
rpoS RpoS 4 989 – 969 CCG AGC TCC TCG CGG AAC AGC GCT TCG AT
SacI
as
rpoS RpoS 4c 1129 – 1109 CCC AAG CTT TTA CTC GCG GAA CAG CGC TTC
HindIII
as
rpoS RpoS 5 572 – 589 ATG AAC CAA GTG GG AAG s
rpoS RpoS 6 871 – 854 ACA TCT TCC AGT GTT GCC as
nlpD RpoS 8 (- 657) – (- 636) CCC AAG CTT CGA CGC AGC AGA GCA AGG AGT T
HindIII
s
rpoS RpoS 9 1141 – 1119 CCC AAG CTT CAG CTG GTG CGC AAG ATG ATG AA
HindIII
as
rpoS RpoS 17a 706 – 736 GAC ATC CTG GCC GAT GAA AAA GAG AAC GGT C s
rpoS RpoS 17b 736 – 706 GAC CGT TCT CTT TTT CAT CGG CCA GGA TGT C as
rpoS RpoS 22 (+ 171) – (+ 151) CCC AAG CTT GCC AAA TGT GAC GCT GAC GCG
HindIII
as
Primers used in this study are listed with their 5' – 3' sequences. All nucleotide positions refer to the start codon of their target gene. Positions of 
RpoS primers within rpoS, nlpD or the flanking regions are referenced to the open reading frame of rpoS. Positions 5' upstream of the start codon 
are indicated with a negative sign, positions 3' downstream of the stop codon with a positive one. s = sense, as = antisenseBMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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activity of pSC2, pMH33 and all other cloned rpoS genes
(Fig. 2) was evaluated with the one step test described
above for acid resistance screening. EHEC 126814 trans-
formed with pBR322 was used as reference strain for these
experiments.
Abbreviations
ATCC, American Type Culture Collection; BCCM, Belgian
Co-ordinated Collections of Microorganisms; CFU, col-
ony forming units; EHEC, enterohemorrhagic E. coli;
HUS, hemolytic uremic syndrome; EcN, E. coli Nissle
1917
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Table 3: Plasmids used in this study.
Plasmid Description Host
pUC19 • High copy plasmid [41]; accession # L09137
• AmpR
• E. coli DH5α
pGP704 • Suicide vector [33]
• Backbone from pBR322, ori R6K instead of ori E1 from pBR322, mob region from pRP4
• Replicates in E. coli SM10λpir but not in EHEC strains used because ori R6K needs π-Protein coded by the pir 
gene for replication
• AmpR
• E. coli SM10λpir
pMHH1 • Derivative of pGP704
• Has a positive selection system based on the sacB gene from Bacillus subtilis [38]
• E. coli SM10λpir
pMHH6* • Derivative of pUC19
• Harbors a 990 bp rpoS fragment from EHEC 86-24 amplified with primers RpoS 3/RpoS 4 and cloned via XbaI 
und SacI restriction sites
• E. coli DH5α
pMHH7* • Derivative of pMHH6
• Restriction digest with DraIII und BsaAI leads to a 390 bp deletion in rpoS
• E. coli DH5α
pMHH8* • Derivative of pMHH1
• Contains the mutagnized 600 bp rpoS fragment from pMHH7 cloned via XbaI and SacI restriction sites
• E. coli SM10λpir
pBR322 • Low copy plasmid [36]; accession # J01749
• AmpR, TetR
• E. coli DH5α
• EHEC 126814
pSC1* • Derivative of pBR322
• Harbors nlpD-rpoS from EHEC 126814 accession # DQ272417 amplified by PCR using primers RpoS 8/RpoS 9 
and cloned via HindIII restriction sites
• E. coli DH5α
• E. coli MHH126-5
pSC2* • Derivative of pBR322
• Harbors nlpD-rpoS from EHEC EDL933a (rpoS*) accession # DQ272419 amplified by PCR with primers RpoS 8/
RpoS 9 and cloned via HindIII restriction sites
• E. coli DH5α
• E. coli MHH126-5
pMH33* • Made from pSC2 by PCR mutagenesis using Primers RpoS 17a/RpoS 17b
• Has point mutation rpoST721G which resolves the TAA stop codon at position 723 in 
• E. coli MHH126-5
pUD2* • Derivative of pBR322
• Harbors nlpD-rpoS from EHEC EDL933b accession # DQ272421 amplified by PCR with primers RpoS 8/RpoS 9 
and cloned via HindIII restriction sites
• E. coli MHH126-5
pUD4* • Derivative of pBR322
• Harbors nlpD-rpoS from EHEC 86-24 accession # DQ272418 amplified by PCR with primers RpoS 8/RpoS 9 and 
cloned via HindIII restriction sites
• E. coli MHH126-5
pUD8* • Derivative of pBR322
• Harbors nlpD-rpoS from STEC E-D53 accession # DQ272423 amplified by PCR with primers RpoS 8/RpoS 9 and 
cloned via HindIII restriction sites
• E. coli MHH126-5
pUD6* • Derivative of pBR322
• Harbors nlpD-rpoS from STEC E-D68 accession # DQ272424 amplified by PCR with primers RpoS 8/RpoS 4c 
and cloned via HindIII restriction sites
• E. coli MHH126-5
pUD9* • Derivative of pBR322
• Harbors nlpD-rpoS from STEC E-D68 accession # DQ272424 amplified by PCR with primers RpoS 8/RpoS 4c 
and cloned via HindIII restriction sites
• E. coli MHH126-5
pUD10* • Derivative of pBR322
• Harbors nlpD-rpoS from EHEC 288597 accession # DQ272422 amplified by PCR with primers RpoS 8/RpoS 9 
and cloned via HindIII restriction sites
• E. coli MHH126-5
pDS4* • Derivative of pBR322
• Harbors nlpD-rpoS from EcN amplified by PCR with primers RpoS 8/RpoS 22 and cloned via HindIII restriction 
sites
• E. coli MHH126-5
All plasmids used in this study are listed with their names, descriptions and host strains. Sequenced rpoS genes were submitted to GenBank. Their 
accession numbers are given in the table. * = plasmid designed in this study
rpoSEDL933aBMC Microbiology 2007, 7:21 http://www.biomedcentral.com/1471-2180/7/21
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Construction of suicide vector pMHH8 Figure 3
Construction of suicide vector pMHH8. The rpoS gene from EHEC 86-24 was amplified by PCR with primers RpoS 3/
RpoS 4 and cloned into pUC19 after restriction digest with enzymes XbaI and SacI (pMHH6). A 390 bp sequence was deleted 
from the insert through restriction digest with enzymes DraIII and BsaAI leading to plasmid pMHH7. The mutated rpoS gene 
was then cloned into suicide vector pMHH1 after restriction digest with XbaI and SacI. The resulting plasmid was termed 
pMHH8. It was used in the construction of all rpoS deletion mutants described in this study.
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Construction of complementation plasmids Figure 4
Construction of complementation plasmids. Complementation plasmids pSC1, pSC2, pUD2, pUD4, pUD8, pUD6, 
pUD9, pUD10 and pDS4 were constructed using low copy vector pBR322 as backbone. Each of them harbors one complete 
rpoS gene and the rpoSp promoter [39] from EHEC/STEC strains 126814 (pSC1), EDL933a (pSC2), EDL933b (pUD2), 86-24 
(pUD4), E-D53 (pUD8) and 288597 (pUD10), amplified by PCR with primers RpoS 8/RpoS 9 containing 5' HindIII restriction 
sites. RpoS 8 and RpoS 4c were taken to synthesize the respective DNA fragment from STEC E-D68 in order to generate the 
two independent plasmids pUD6 and pUD9. pDS4 contained the cloned rpoS gene from EcN, amplified with primers RpoS 8 
and RpoS 22. pMH33 was made from pSC2 by PCR mediated site specific mutagenesis, employing the mutation rpoST721G to 
resolve the TAA stop codon in rpoS*. RpoS negative mutant strain E. coli MHH126-5 was transformed with each of the comple-
mentation vectors by electroporation.
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